Food-Related Carbohydrate Ligands for Galectins

Galectins

Volumn , Issue , 2008, Pages 235-270

  Mossine, Valeri V ^a   Glinsky, Vladislav V ^a   Mawhinney, Thomas P ^a  

^a University of Missouri   (United States)

Author keywords

Food galectin binders; Galectin food related carbohydrate ligands; Lactulosamines and glycoaminoconjugates

Indexed keywords

EID: 64949117815     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470378076.ch12     Document Type: Chapter

References (149)

1. Kushak RI, Winter HS. Dietary carbohydrates: digestion and absorption. In: Landlow MV, editor. Trends in Dietary Fats Research. Nova Science Publishers; 2005. p 1-30.
2. Brownlee IA, Dettmar PW, Strugala V, Pearson JP. The interaction of dietary fibres with the colon. Curr Nutr Food Sci 2006;2: 243-264.
3. Meyer D, Tungland B. Non-digestible oligosaccharides and polysaccharides: their physiological effects and health implications. In: McCleary BV, Prosky L, editors. Advanced Dietary Fibre Technology. Oxford, UK: Blackwell Science Ltd; 2001. p 455-470.
4. Tungland BC. Fructooligosaccharides and other fructans: structures and occurrence, production, regulatory aspects, food applications, and nutritional health significance. ACS Symp Ser 2003;849:135-152.
5. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 2000;20:699-722.
6. Lairon D. Dietary fibre, lipid metabolism and cardiovascular disease. In: Van der Kamp JW, editor. Dietary Fibre.Wageningen, Netherlands:Wageningen Academic Publishers; 2004. p 183-195.
7. Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes 1993;42:503-508.
8. Moore MA. Dietary factors for cancer prevention: focus on insoluble and soluble fiber in cereals and vegetables. Foods Food Ingredients J Jpn 2002;196:20-33.
9. Pelucchi C, Talamini R, Galeone C, Negri E, Franceschi S, Dal Maso L, Montella M, Conti E, La Vecchia C. Fibre intake and prostate cancer risk. Int J Cancer 2004;109:278-280.
10. Takenaka Y, Fukumori T, Raz A. Galectin-3 and metastasis. Glycoconj J 2004;19: 543-549.
11. Parsonage G, Trebilcock E, Toscano MA, Bianco GA, Ilarregui JM, Buckley CD, Rabinovich GA. Roles of galectins in chronic inflammatory microenvironments. Future Rheumatol 2006;1:441-454.
12. Soerme P, Kahl-Knutsson B,Wellmar U, Magnusson B-G, Leffler H, Nilsson UJ. Design and synthesis of galectin inhibitors. Methods Enzymol 2003;363:157-169.
13. Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Antigalectin compounds as potential anti-cancer drugs. Curr Med Chem 2006;13: 3513-3527.
14. Ridley BL, O'Neill MA, Mohnen D. Pectins: structure, biosynthesis, and oligogalacturonide- related signaling. Phytochemistry 2001;57:929-967.
15. Voragen AGJ, Pilnik W, Thibault J-F, Axelos MAV, Renard CMGC. Pectins. Food Sci Technol 1996;67:287-339.
16. de Vries JA, Rombouts FM, Voragen AGJ, Pilnik W. Comparison of the structural features of apple and citrus pectic substances. Carbohydr Polym 1984;4:89-101.
17. Rouau X, Thibault J-F. Apple juice pectic substances. Carbohydr Polym 1984;4: 111-125.
18. Dey PM, Brinson K. Plant cell-walls. Adv Carbohydr Chem Biochem 1984;42:265-382.
19. Hinz SWA, Verhoef R, Schols HA, Vincken J-P, Voragen AGJ. Type I arabinogalactan contains b-D-Galp-(1!3)-b-D-Galp structural elements. Carbohydr Res 2005;340: 2135-2143.
20. Pérez S, Mazeau K, Hervé du Penhoat C. The three-dimensional structures of the pectic polysaccharides. Plant Physiol Biochem 2000;38:37-55.
21. Engelsen SB, Cros S, Mackie W, Pérez S. A molecular builder for carbohydrates: application to polysaccharides and complex carbohydrates. Biopolymers 1996;39: 417-433.
22. Baker RA. Reassessment of some fruit and vegetable pectin levels. J Food Sci 1997;62:225-229.
23. Rolin C. Commercial pectin preparations. In: Seymour GB, Knox JP, editors. Pectins and Their Manipulation. Oxford, UK: Blackwell Publishing Ltd; 2002. p 222-241.
24. Groman EV, Enriquez PM, Jung C, Josephson L. Arabinogalactan for hepatic drug delivery. Bioconjug Chem 1994;5:547-556.
25. Gaspar Y, Johnson KL, McKenna JA, Bacic A, Schultz CJ. The complex structures of arabinogalactan-proteins and the journey towards understanding function. Plant Mol Biol 2001;47:161-176.
26. Williams PA, Phillips GO. Gum arabic. In: Phillips GO,Williams PA, editors. Handbook of Hydrocolloids. Cambridge, UK: Woodhead Publishing Ltd.; 2000. p 155-168.
27. Street CA, Anderson DMW. Refinement of structures previously proposed for gum arabic and other Acacia tree exudates. Talanta 1983;30:887-895.
28. Platt D, Raz A. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst 1992;84:438-442.
29. Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst 1995;87: 348-353.
30. Staples M, Rolke J. Modified pectins, compositions and methods related thereto. WO 2005/095463.2005.
31. Mitchell CR, Mitchell PR. Treated pectinic acid process and product. US Patent 5,498,702, 1996.
32. Inohara H, Raz A. Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J 1994;11:527-532.
33. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 2002;94:1854-1862.
34. Luck K, Ehwald R, Ziska P, Koppitz H. Affinity sorbent for galactose specific lectins consisting of deproteinized plant cell wall ghosts. Plant Sci 1992;82:29-35.
35. Benhamou N, Gilboa-Garber N, Trudel J,Asselin A. A newlectin-gold complex for ultrastructural localization of galacturonic acids. J Histochem Cytochem 1988;36: 1403-1411.
36. Koppitz H,Woehlecke H, Ehwald R. Crosslinking treatment for increasing lectin binding capacity of a vesicular affinity sorbent consisting of higher plant cells walls. Phytochemistry 1994;35:1205-1213.
37. Vincken J-P, Schols HA, Oomen RJFJ, McCann MC, Ulvskov P, Voragen AGJ, Visser RGF. If homogalacturonan were a side chain of rhamnogalacturonan I. Implications for cell wall architecture. Plant Physiol 2003;132:1781-1789.
38. Chauhan D, Li G, Podar K, Hideshima T, Neri P, He D, Mitsiades N, Richardson P, Chang Y, Schindler J, Carver B, Anderson KC. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells. Cancer Res 2005;65: 8350-8358.
39. Dongowski G, Anger H. Metabolism of pectin in the gastrointestinal tract. Prog Biotechnol 1996;14 (Pectins and Pectinases):659-666.
40. Gulfi M, Arrigoni E, Amado R. In vitro fermentability of a pectin fraction rich in hairy regions. Carbohydr Polym 2007;67:410-416.
41. Jenkins DJA, Leeds AR, Gassull MA, Wolever TMS, Goff DV, Alberti KGMM, Hockaday TDR. Unabsorbable carbohydrates and diabetes: decreased postprandial hyperglycemia. Lancet 1976;2:172-174.
42. Ellis PR, Rayment P,Wang Q. A physico-chemical perspective of plant polysaccharides in relation to glucose absorption, insulin secretion and the entero-insular axis. Proc Nutr Soc 1996;55:881-898.
43. Keys A, Grande F, Anderson JT. Fiber and pectin in the diet and serum cholesterol concentration in man. Proc Soc Exp Biol Med 1961;106:555-558.
44. Furda I. Interaction of dietary fiber with lipids--mechanistic theories and their limitations. Adv Exp Med Biol 1990;270:67-82.
45. Hirano M, Matsumoto T, Kiyohara H, Yamada H. Lipopolysaccharide-independent Limulus amebocyte lysate activating, mitogenic and anti-complementary activities of pectic polysaccharides from Chinese herbs. Planta Med 1994;60:248-252.
46. Samuelsen AB, Paulsen BS, Wold JK, Otsuka H, Kiyohara H, Yamada H, Knutsen SH. Characterization of a biologically active pectin from Plantago major L. Carbohydr Polym 1996;30:37-44.
47. Popov SV, Golovchenko VV, Ovodova RG, Smirnov VV, Khramova DS, Popova GY, Ovodov YS. Characterisation of the oral adjuvant effect of lemnan, a pectic polysaccharide of Lemna minor L. Vaccine 2006;24:5413-5419.
48. Hetland G, Samuelsen AB, Lovik M, Paulsen BS, Aaberge IS, Groeng E-C, Michaelsen TE. Protective effect of Plantago major L. pectin polysaccharide against systemic Streptococcus pneumoniae infection in mice. Scand J Immunol 2000;52:348-355.
49. Kupchik LA, Kartel' NT, Bogdanov ES, Bogdanova OV, Kupchik MP. Chemical modification of pectin to improve its sorption properties. Russ J Appl Chem 2006;79:457-460.
50. Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res 2006;20:859-864.
51. Motomura Y, Yoshida Y. Antioxidative ability of cell wall components in fruits against ascorbic acid oxidation. Acta Hort 2003;628:669-676.
52. Harris PJ, Ferguson LR. Dietary fibre: its composition and role in protection against colorectal cancer. Mutat Res 1993;290:97-110.
53. Ohkami H, Tazawa K, Yamashita I, Shimizu T, Murai K, Kobashi K, Fujimaki M. Effects of apple pectin on fecal bacterial enzymes in azoxymethane-induced rat colon carcinogenesis. Jpn J Cancer Res 1995;86:523-529.
54. Ohno K, Narushima S, Takeuchi S, Itoh K, Mitsuoka T, Nakayama H, Itoh T, Hioki K, Nomura T. Inhibitory effect of apple pectin and culture condensate of Bifidobacterium longum on colorectal tumors induced by 1,2-dimethylhydrazine in transgenic mice harboring human prototype c-Ha-ras genes. Exp Anim 2000;49: 305-307.
55. Klurfeld DM. Dietary fiber-mediated mechanisms in carcinogenesis. Cancer Res 1992;52 (7 Suppl):2055s-2059s.
56. Beuth J, Ko HL, Oette K, Pulverer G, Roszkowski K, Uhlenbruck G. Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol 1987;113:51-55.
57. Beuth J,Ko HL, Schirrmacher V, Uhlenbruck G, Pulverer G. Inhibition of liver tumor cell colonization in two animal models by lectin blocking with D-galactose and arabinogalactan. Clin Exp Metastasis 1988;6:115-120.
58. Hagmar B, Erkell LJ, Ryd W, Skomedal H. Effect of arabinogalactan and other glycoconjugates on experimental metastases. Cell Pharmacol 1994;1:87-90.
59. Hagmar B, Ryd W, Skomedal H. Arabinogalactan blockade of experimental metastases to liver by murine hepatoma. Invasion Metastasis 1991;11:348-355.
60. Glinskii OV, Huxley VH, Glinsky GV, Pienta KJ, Raz A, Glinsky VV. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 2005;7:522-527.
61. Hayashi A, Gillen AC, Lott JR. Effects of daily oral administration of quercetin chalcone and modified citrus pectin in implanted colon-25 tumor growth in Balb-c mice. Altern Med Rev 2000;5:546-552.
62. Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis 2003;6:301-304.
63. Adachi S. N-p-Tolyl-lactosylamine and its Amadori rearrangement product. Chem Ind 1957;956.
64. Kuhn R, Krüger G. Interaction of Amadori compounds with diazonium salts. Liebigs Ann Chem 1959;628:240-255.
65. GlinskyGV, MossineVV, Price JE, BieleubergD,Glinsky VV, Ananthaswamy H, Feather MS. Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs. Clin Exp Metastasis 1996;14:253-267.
66. Finot PA, Mauron J. The blockage of lysine in the Maillard reaction. II. Chemical properties of N-(deoxy-1-D-fructosyl-1) and N-(deoxy-1-D-lactulosyl-1) derivatives of lysine. Helv Chim Acta 1972;55:1153-1164.
67. Krause R, Knoll K, Henle T. Studies on the formation of furosine and pyridosine during acid hydrolysis of different Amadori products of lysine. Eur Food Res Technol 2003;216:277-283.
68. Olano A, Santa-Maria G, Corzo N, Calvo MM, Martinez-Castro I, Jimeno ML. Determination of free carbohydrates and Amadori compounds formed at the early stages of non-enzymic browning. Food Chem 1992;43:351-358.
69. Mossine VV, Barnes CL, Glinsky GV, Feather MS. Interaction between two C(1)-X-C0 (1) branched ketoses: observation of an unprecedented crystalline spiro-bicyclic hemiketal tautomer of N,N-di(1-deoxy-D-fructos-1-yl)-glycine ("difructose glycine") having open chain carbohydrate. Carbohydr Lett 1995;1:355-362.
70. Hashiba H. The browning reaction of Amadori compounds derived from various sugars. Agric Biol Chem 1982;46:547-548.
71. Mossine VV, Mawhinney TP. D-Fructose-L-histidine: a potent copper chelator from tomato powder. J Agric Food Chem 2007;55:10373-10381.
72. Mossine VV, Linetsky M, Glinsky GV, Ortwerth BJ, Feather MS. Superoxide free radical generation by Amadori compounds: the role of acyclic forms and metal ions. Chem Res Toxicol 1999;12:230-236.
73. Mossine VV, Feather MS. Metal binding properties of glycated amino acids and proteins. In: The Maillard Reaction in Foods and Medicine. London: The Royal Society of Chemistry;1998. p 429.
74. Finot PA, Deutsch R, Bujard E. The extent of the Maillard reaction during the processing of milk. Prog Food Nutr Sci 1981;5:345-355.
75. Erbersdobler HF. Protein reactions during food processing and storage--their relevance to human nutrition. In: Somogyi JC, Müller HR, editors. Nutritional Impact of Food Processing. Karger: Basel;1989. p 140-155.
76. Berg HE, van Boekel MAJS. Degradation of lactose during heating of milk. 1. Reaction pathways. Neth Milk Dairy J 1994;48:157-175.
77. Rérat A, Calmes R, Vaissade P, Finot P-A. Nutritional and metabolic consequences of the early Maillard reaction of heat treated milk in pig. Significance for man. Eur J Nutr 2002;41:1-11.
78. Matsuda T, Kato Y. Haptenic sugar antigens as immunochemical markers for the Maillard reaction of processed and stored milk products. ACS Symp Ser 1996;631:221-226.
79. Pizzano R, Nicolai MA, Siciliano R, Addeo F. Specific detection of the Amadori compounds in milk by using polyclonal antibodies raised against a lactosylated peptide. J Agric Food Chem 1998;46:5373-5379.
80. Pallini M, Compagnone D, Palleschi G, Di Stefano S, Marini S, Coletta M. Immunodetection of lactosylated proteins as a useful tool to determine heat treatment in milk samples. Analyst 2001;126:66-70.
81. Siciliano R, Rega B, Amoresano A, Pucci P. Modern mass spectrometric methodologies in monitoring milk quality. Anal Chem 2000;72:408-415.
82. Czerwenka C, Maier I, Pittner F, Lindner W. Investigation of the lactosylation of whey proteins by liquid chromatography-mass spectrometry. J Agric Food Chem 2006;54: 8874-8882.
83. Erbersdobler HF. The biological significance of carbohydrate-lysine crosslinking during heat-treatment of food proteins. Adv Exp Med Biol 1977;86B: 367-378.
84. Dworschák E, Tarján V, Turos S. Characteristics of some new flavoring materials produced by the Maillard reaction. ACS Symp Ser 1983;215:159-168.
85. Desrosiers T, Savoie L, Bergeron G, Parent G. Estimation of lysine damage in heated whey proteins by furosine determinations in conjunction with the digestion cell technique. J Agric Food Chem 1989;37:1385-1391.
86. Holt C, McPhail D, Nevison I, Nylander T, Otte J, Ipsen RH, Bauer R, Ogendal L, Olieman K, De Kruif KG, Leonil J, Molle D, Henry G, Maubois JL, Perez MD, Puyol P, Calvo M, Bury SM, Kontopidis G, McNae I, Sawyer L, Ragona L, Zetta L, Molinari H, Klarenbeek B, Jonkman MJ, Moulin J, Chatterton D. Apparent chemical composition of nine commercial or semi-commercial whey protein concentrates, isolates and fractions. Int J Food Sci Technol 1999;34:543-556.
87. Oak J-H, Nakagawa K, Miyazawa T. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples. J Lipid Res 2002;43:523-529.
88. Kumar V, Banker GS. Maillard reaction and drug stability. Spec Pub R Soc Chem 1994;151 (Maillard Reactions in Chemistry Food and Health): 20-27.
89. Wirth JJ, Olsen BA, Hallenbeck DK, Lake ME, Gregg SM, Perry FM. Screening methods for impurities in multi-sourced fluoxetine hydrochloride drug substances and formulations. Chromatographia 1997;46:511-523.
90. Aring J, Schlepper-Schaefer J, Burkart V, Kolb H. Nonenzymatically glycated serum albumin: interaction with galactose-specific liver lectins. Biochim Biophys Acta 1989;1010:140-144.
91. Glinsky GV. Glycodeterminants of melanoma cell adhesion. A model for antimetastatic drug design. Crit Rev Oncol Hematol 1993;14:1-13.
92. Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Cancer Res 1996;56:5319-5324.
93. Weis WI, Drickamer K. Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem 1996;65:441-473.
94. Rabinovich GA, Cumashi A, Bianco GA, Ciavardelli D, Iurisci I, D'Egidio M, Piccolo E, Tinari N, Nifantiev N, Iacobelli S. Synthetic lactulose-amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis. Glycobiology 2006;16:210-220.
95. Huflejt ME, Mossine VV, Croft M. Galectin-1 and galectin-4 in tumor development and use in prognosis and treatment of breast cancer. PCT Int Appl WO 0326494 A2.2003.
96. Pellegrino L, De Noni I, Cattaneo S. Formation of protein bound lysine-derived galactosyl and glucosyl pyrroles in heated model systems. Nahrung 2000;44:193-200.
97. Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Cordone S, Gradini R, Barsotti P, Liu F-T, Di Mario U, Pugliese G. Role of galectin-3 as a receptor for advanced glycosylation end products. Kidney Int Suppl 2000;77:S31-S39.
98. Raz A, Lotan R. Lectin-like activities associated with human and murine neoplastic cells. Cancer Res 1981;41:3642-3647.
99. Denisevich TV, Semyonova-Kobzar RA, Glinsky VV, Mossine VV. The influence of synthetic aminoglycoconjugates on the aggregation ability and metastatic potential of tumor cells. Exp Oncol 1995;17:111-117.
100. Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ, Quinn TP. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003;63:3805-3811.
101. Springer GF. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med 1997;75:594-602.
102. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 2001;61:4851-4857.
103. Khaldoyanidi SK, Glinsky VV, Sikora L, Glinskii AB, Mossine VV, Quinn TP, Glinsky GV, Sriramarao P. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 2003;278:4127-4134.
104. Johnson KD, Glinskii OV, Mossine VV, Turk JR, Mawhinney TP, Anthony DC, Henry CJ, Huxley VH, Glinsky GV, Pienta KJ, Raz A, Glinsky VV. Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelium. Neoplasia 2007;9:662-670.
105. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-739.
106. Hurrell RF, Finot PA, Ford JE. Storage of milk powders under adverse conditions. 1. Losses of lysine and of other essential amino acids as determined by chemical and microbiological methods. Br J Nutr 1983;49:343-354.
107. Hurrell RF. Influence of the Maillard reaction on the nutritional value of foods. In: Finot PA, Aeschbacher HU, Hurrell RF, Liardon R, editors. The Maillard Reaction in Food Processing, Human Nutrition and Physiology. Basel: Birkhäuser Verlag;1990. p 245-258.
108. Henle T, Schwenger V, Ritz E. Preliminary studies on the renal handling of lactuloselysine from milk products. Czech J Food Sci 2000;18:101-102.
109. Schwenger V, Morath C, Schönfelder K, Klein W, Weigel K, Deppisch R, Henle T, Ritz E, Zeier M. An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients. Nephrol Dial Transplant 2006;21: 383-388.
110. Langhendries JP, Hurrell RF, Furniss DE, Hischenhuber C, Finot PA, Bernard A, Battisti O, Bertrand JM, Senterre J. Maillard reaction products and lysinoalanine: urinary excretion and the effects on kidney function of preterm infants fed heat-processed milk formula. J Pediatr Gastroenterol Nutr 1992;14:62-70.
111. Albert R, Marbach P, Bauer W, Briner U, Fricker G, Bruns C, Pless J. SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity. Life Sci 1993;53:517-525.
112. Hurley TR, Lovdahl MJ, Tobias B. Pregabalin lactose conjugates. PCT Int Appl WO 078747 A3.2002.
113. Glinskii OV, Huxley VH, Glinsky GV, Pienta KJ, Raz A, Glinsky VV. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 2005;7:522-527.
114. Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE. Galectin-1 receptors in different cell types. J Biomed Sci 2005;12:13-29.
115. Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006;1760:616-635.
116. Wielinga WC. Galactomannans. In: Phillips GO, Williams PA, editors. Handbook of Hydrocolloids. Cambridge, UK: Woodhead Publishing Ltd.;2000. p 137-154.
117. Nishinari K, Yamatoya K, Shirakawa M. Xyloglucan. In: Phillips GO, Williams PA, editors. Handbook of Hydrocolloids. Cambridge, UK:Woodhead Publishing Ltd.; 2000. p 247-267.
118. Fischer MH, Yu N, Gray GR, Ralph J, Anderson L, Marlett JA. The gel-forming polysaccharide of psyllum husk (Plantago ovata Forsk). Carbohydr Res 2004;339: 2009-2017.
119. Singh B. Psyllium as therapeutic and drug delivery agent. Int J Pharm 2007;334:1-14.
120. Cui W, Eskin MNA, Biliaderis CG, Marat K. NMR characterization of a 4-O-methyl-b-D-glucuronic acid-containing rhamnogalacturonan from yellow mustard (Sinapis alba L.) mucilage. Carbohydr Res 1996;292:173-183.
121. Warrand J, Michaud P, Picton L, Muller G, Courtois B, Ralainirina R, Courtois J. Structural investigations of the neutral polysaccharide of Linum usitatissimum L. seeds mucilage. Int J Biol Macromol 2005;35:121-125.
122. Cui SW, Eskin MAN,Wu Y, Ding S. Synergisms between yellow mustard mucilage and galactomannans and applications in food products--a mini review. Adv Colloid Interface Sci 2006;128-130,249-256.
123. Tarpila A,Wennberg T, Tarpila S. Flaxseed as a functional food. Curr Top Nutraceut Res 2005;3:167-188.
124. Tischer CA, Iacomini M, Gorin PAJ. Structure of the arabinogalactan from gum tragacanth (Astragalus gummifer). Carbohydr Res 2002;337:1647-1655.
125. Aspinall GO, Baillie J. Gum tragacanth. Part II. The arabinogalactan. J Chem Soc 1963;1714-1721.
126. Aspinall GO. Gums and mucilages. Adv Carbohydr Chem 1969;24:333-379.
127. Wang W. Tragacanth and karaya. In: Phillips GO, Williams PA, editors. Handbook of Hydrocolloids. Cambridge, UK: Woodhead Publishing Ltd.; 2000. p 231-246.
128. Stortz CA. Carrageenans: structural and conformational studies. In:Yarema KJ, editor. Handbook of Carbohydrate Engineering. Boca Raton, FL: CRC Press LLC; 2005. p 211-245.
129. Mehra R,Kelly P. Milk oligosaccharides: structural and technological aspects. Int Dairy J 2006;16:1334-1340.
130. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 2000;71:1589-1596.
131. Chaturvedi P,Warren CD, Buescher CR, Pickering LK, Newburg DS. Survival of human milk oligosaccharides in the intestine of infants. Adv Exp Med Biol 2001;501:315-323.
132. Martin-Sosa S, Martin M-J, Hueso P. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J Nutr 2002;132:3067-3072.
133. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R, Orazio G. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 2006;59:377-382.
134. Newburg DS. Human milk glycoconjugates that inhibit pathogens. Curr Med Chem 1999;6:117-127.
135. Perret S, Sabin C, Dumon C, Pokorna M, Gautier C, Galanina O, Shahov I, Bovin N, Nicaise M, Desmadril M, Gilboa-Garber N, Wimmerov M, Mitchell EP, Imberty A. Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa. Biochem J 2005;389:325-332.
136. Gopal PK, Gill HS. Oligosaccharides and glycoconjugates in bovine milk and colostrum. Br J Nutr 2000;84 (Suppl. 1):S69-S74.
137. Sparrow CP, Leffler H, Barondes SH. Multiple soluble b-galactoside-binding lectins from human lung. J Biol Chem 1987;262:7383-7390.
138. Ahmed H, Fink NE, Pohl J, Vasta GR. Galectin-1 from bovine spleen: biochemical characterization, carbohydrate specificity and tissue-specific isoform profiles. J Biochem 1996;120:1007-1019.
139. Leffler H,Barondes SH. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian b-galactosides. J Biol Chem 1986;261: 10119-10126.
140. Ideo H, Seko A, Ohkura T, Matta KL, Yamashita K. High-affinity binding of recombinant human galectin-4 to SO3- ! 3Galb1 ! 3GalNAc pyranoside. Glycobiology 2002;12: 199-208.
141. Ahmad N, Gabius H-J, Kaltner H, Andre S, Kuwabara I, Liu F-T, Oscarson S, Norberg T, Brewer CF. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3, and -7: evidence for differential binding specificities. Can J Chem 2002;80:1096-1104.
142. Ideo H, Seko A, Ishizuka I, Yamashita K. The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 2003;13:713-723.
143. Sako T, Matsumoto K, Tanaka R. Recent progress on research and applications of nondigestible galacto-oligosaccharides. Int Dairy J 1999;9:69-80.
144. Aider M, de Halleux D. Isomerization of lactose and lactulose production: review. Trends Food Sci Technol 2007;18:356-364.
145. Mesters PHJ, Van Velthuijsen JA, Brokx S. Lactitol: a new reduced-calorie sweetener. Food Sci Technol 2001;112:297-315.
146. Arakawa K, Aoyama Y, Ikeda H, Mikuni K, Fujita K, Hara K. The development of lactosucrose production and its applications in foods for specified health use. J Appl Glycosci 2002;49:63-72.
147. Singh A, Porwal O, Sharma N, Singh A, Kumar S, Sharma PK. Effects of prebiotics on gut and human health: a review. J Pure Appl Microbiol 2007;1:69-82.
148. Kalach N, Rocchiccioli F, de Boissieu D, Benhamou PH, Dupont C. Intestinal permeability in children: variation with age and reliability in the diagnosis of cow's milk allergy. Acta Paediatr 2001;90:499-504.
149. Anderson ADG, Jain PK, Fleming S, Poon P, Mitchell CJ, MacFie J. Evaluation of a triple sugar test of colonic permeability in humans. Acta Physiol Scand 2004;182:171-177.